REFERENCES


Gene Name Pubmed ID Classification Sample Location Remark
RASSF1 17971771MethylationVU University Medical Center in AmerstdamRASSF1A is significantly more frequently methylated in adenocarcinomas with 37.5% frequency.  
RASSF1 18608185MethylationDepartment of Gynecology, JawaharLal Nehru Medical College and Hospital, AligarhAberrant methylation of RASSF1A gene is found in 35% of cases of cervix cancer.  
RASSF1 19469170-Department of Pathology of Cancer Hospital, Shanxi.Microsatellite alterations of RASSF1A gene is significant for cervical cancer. RASSF1A gene change is a relatively late event in cervical carcinoma.  
RASSF1 17360030MethylationNational Cancer Center, Korea and Cheil Hospital, KoreaGenetic or epigenetic alteration in RAS pathway including a mutation in RASSF1A methylation has been reported to play an important role in cervical cancer development.  
RASSF1 15612586MethylationDivision of Pathological Anatomy of Human Tumors of Blokhin Cancer Research Center, Russian Academy of Medical Sciences.RASSF1A gene is methylated in in genesis of tumor of cervical and its expression level increses with tumor progression  
RASSF1 12912945MethylationSamsung Cheil Hospital, Seoul, KoreaHypermethylation of the RASSF1A promoter region is common in adenocarcinoma of the uterine cervix and rare in squamous carcinoma of uterine cervix. And methylation of promoter has been found in 45% of AC>  
RASSF1 12702579Methylation-Presence of HPVs in cervical carcinoma may alleviate the requirement for RASSF1A inactivation, a tumor suppressor gene. RASSF1A promoter is methylated in 10% of squamous cell carcinomas, 21% of adenocarcinoma and 24% of cervical adenocarcinoma.  
RASSF1 12673680Methylation-Hypermethylation of tumor suppressor gene RASSF1A occurs in cervical cancer in which concomitant loss of heterozygosity at 3p21 is common.Hypermethylation of RASSF1A is detected in 30% of SCC and 12% of AC.  
RASSF1 16331610MethylationGynecologic Oncology Division of Seoul National University HospitalThis gene is more methylated in AC than SCC (9.7%,P=0.008)  
RASSF1 17097722MethylationTri-Service General Hospital, TaiwanIn AC, the promoter of RASSF1A is hypermethylated in 26.1% of patients, which indicates that RASSF1A hypermethylation may play an essential role in cervical adenocarcinoma.  
RASSF1 15948711Methylation-There is an inverse correlation between methylation of RASSF1A and HPV.  
RASSF1 19836067MethylationChonnam National University Hwasun HospitalThe trend of methylation of this gene is increasing with increasing severity of cervical squamous lesions (p<0.001).  
RASSF1 15589597MethylationDepartment of Obstertics and Gynecology, Seoul national University Hospital.Frequency of methylation of this gene is found to be 12.2%.  
RASSF1 17097722Methylation-The RASSF1A was methylated in 15% of SCC, 17.5% of HSIL, but not in LSIL or normal tissues (P<0.001). In AC, 43.5% of patients showed BLU methylation and 26.1% RASSF1A methylation  
RASSF1 12773202Methylation-high frequency of promoter methylation in CDH1, DAPK, RARB, and HIC1 genes